Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IONS✓SelectedUSD · IONSGSK vs IONS performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs IONS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.4%
IONS return
-13.7%
Excess return
+60.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioIONSExcessAlpha
1D-0.1%-3.6%+3.5%+0.2%
7D-1.3%-9.6%+8.3%-0.5%
30D+2.7%-34.8%+37.5%+6.1%
3M+2.7%-51.1%+53.8%+8.7%
6M+3.3%-62.3%+65.6%+11.4%
YTD+6.5%-64.6%+71.1%+15.4%
1Y+10.7%-60.9%+71.5%+18.9%
3Y+64.4%-42.3%+106.6%+67.2%
All+46.4%-13.7%+60.1%+47.9%

Cumulative growth

Daily Returns

Daily percentage return beside IONS.

Daily Out/Under-Performance

Portfolio return minus IONS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IONS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded IONS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling